OliX Pharmaceuticals   Report issue

For profit Phase 1 Phase 2
Founded: Suwon-si Korea, Republic of (2010)

Organization Overview

First Clinical Trial
2018
NCT03569267
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

OliX Pharmaceuticals | Olix Pharmaceuticals, Inc.